Clinical Trial Update: Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 efficacy study evaluating chemotherapy for advanced or recurrent endometrial cancer; sponsor is Asan Medical Center; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced or Recurrent Endometrial Cancer | Phase 2 | Status: UNKNOWN